The novel approach of tirzepatide peptide represents a major advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment